Ipca Laboratories per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹51.63₹44.98₹29.08₹21.57₹18.58
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹51.63₹44.98₹29.08₹21.57₹18.58
₹317.85₹317.85₹273.88₹249.59₹230.27
₹399.12₹380.23₹352.37₹303.71₹246.13
—₹45.01₹52.08₹37.23₹31.76
₹19.30₹19.30₹21.51₹21.02₹12.27
—₹2.07₹4.00₹2.00₹4.00
25.425.425.425.425.4
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

IPCALAB₹1,930.50

Ipca Laboratories Ltd.

· Pharma & Health
₹ CrorePeersTORNTPHARMALKEMJBCHEPHARMABBOTINDIAAJANTPHARMANTHEMGLAXOMEDANTAMcap ₹48,977 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS18.5821.5729.0844.9851.63
Diluted EPS18.5821.5729.0844.9851.63
Book Value per Share230.27249.59273.88317.85317.85
Revenue per Share246.13303.71352.37380.23399.12
Cash Flow per Share31.7637.2352.0845.01—
Free Cash Flow per Share12.2721.0221.5119.3019.30
Dividends per Share4.002.004.002.07—
Shares Outstanding (cr)25.425.425.425.425.4
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.